0000950170-23-071875.txt : 20231220 0000950170-23-071875.hdr.sgml : 20231220 20231220160527 ACCESSION NUMBER: 0000950170-23-071875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kohli Prashant CENTRAL INDEX KEY: 0001946739 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35776 FILM NUMBER: 231501373 MAIL ADDRESS: STREET 1: 206 CAMBRIDGE LANE CITY: NEWTOWN STATE: PA ZIP: 13940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acasti Pharma Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-649-9272 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 ownership.xml 4 X0508 4 2023-12-19 0001444192 Acasti Pharma Inc. ACST 0001946739 Kohli Prashant 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 true true false false Chief Executive Officer false Stock Options (Right to Buy) 2.125 2023-12-19 4 A false 41668 0 A 2033-12-19 Class A Common Shares 41668 41668 D Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which fully vested upon grant. /s/ Prashant Kohli 2023-12-20